Bosch UK: against COVID-19 Company
Entity: Bosch UK
Category: Test Kits
Description: The Bosch Group is a global supplier of technology and services. It employs roughly 390,000 associates worldwide (as of December 31, 2016). According to preliminary figures, the company generated sales of 73.1 billion euros in 2016. Its operations are divided into four business sectors: Mobility Solutions, Industrial Technology, Consumer Goods, and Energy and Building Technology. As a leading IoT company, Bosch offers innovative solutions for smart homes, smart cities, connected mobility, and connected industry. It uses its expertise in sensor technology, software, and services, as well as its own IoT cloud, to offer its customers connected, cross-domain solutions from a single source. The Bosch Group’s strategic objective is to create solutions for a connected life and to improve quality of life worldwide with products and services that are innovative and spark enthusiasm. In short, Bosch creates technology that is “Invented for life.” The Bosch Group comprises Robert Bosch GmbH and its roughly 450 subsidiaries and regional companies in some 60 countries.
1. Project: Bosch rapid COVID-19 test + Randox
Summary: Bosch UK develops rapid test for COVID-19. Reliable test results enable differential diagnosis in under 2.5 hours. Bosch is supporting medical facilities such as doctors’ offices, hospitals, laboratories, and health centres with its new COVID-19 rapid test. The rapid test can diagnose ten respiratory pathogens simultaneously for differential diagnosis and meets the requirements of the World Health Organisation (WHO). Bosch Healthcare Solutions, together with Randox Laboratories Ltd., has developed one of the world’s first fully automated molecular diagnostic tests. The test is currently available on a laboratory-based system which tests up to 324 samples in 8 hours. Randox and Bosch Healthcare are working to make available a point of care test which can give results in less time.
The coronavirus SARS-CoV-2 is posing major challenges for healthcare systems and medical institutions worldwide. An ability to rapidly diagnose the virus is of invaluable help in curbing its exponential spread in many countries. Bosch’s new, fully automated rapid test for COVID-19 can help medical facilities such as doctors’ offices, hospitals, laboratories, and health centres make fast diagnoses. The rapid molecular diagnostic test runs on the Vivalytic analysis device from Bosch Healthcare Solutions. Developed in just six weeks, the rapid test can detect a SARS-CoV-2 coronavirus infection in patients in under two and a half hours – measured from the time the sample is taken to the time the result arrives. Another advantage of the rapid test is that it can be performed directly at the point of care. This eliminates the need to transport samples, which takes up valuable time. It also means patients quickly gain certainty about their state of health, while allowing infected individuals to be identified and isolated immediately. With the tests currently in use, patients must usually wait one to two days for a result.
“We want the Bosch rapid COVID-19 test to play a part in containing the coronavirus pandemic as quickly as possible. It will speed up the identification and isolation of infected patients,” says Dr. Volkmar Denner, chairman of the board of management of Robert Bosch GmbH; “Bosch’s rapid COVID-19 test will help contain the spread of the pandemic and break the chain of transmission more quickly.”
2. Project: Ventilators production + Geomiq
Summary: Bosch UK is working with Geomiq, an online platform that matches design engineers with manufacturers and has a heavy focus on medical devices, to replicate and 3D print the outer shell for vital ventilators. They just need to go-ahead from regulators.
Category: Test Kits
Description: The Bosch Group is a global supplier of technology and services. It employs roughly 390,000 associates worldwide (as of December 31, 2016). According to preliminary figures, the company generated sales of 73.1 billion euros in 2016. Its operations are divided into four business sectors: Mobility Solutions, Industrial Technology, Consumer Goods, and Energy and Building Technology. As a leading IoT company, Bosch offers innovative solutions for smart homes, smart cities, connected mobility, and connected industry. It uses its expertise in sensor technology, software, and services, as well as its own IoT cloud, to offer its customers connected, cross-domain solutions from a single source. The Bosch Group’s strategic objective is to create solutions for a connected life and to improve quality of life worldwide with products and services that are innovative and spark enthusiasm. In short, Bosch creates technology that is “Invented for life.” The Bosch Group comprises Robert Bosch GmbH and its roughly 450 subsidiaries and regional companies in some 60 countries.
1. Project: Bosch rapid COVID-19 test + Randox
Summary: Bosch UK develops rapid test for COVID-19. Reliable test results enable differential diagnosis in under 2.5 hours. Bosch is supporting medical facilities such as doctors’ offices, hospitals, laboratories, and health centres with its new COVID-19 rapid test. The rapid test can diagnose ten respiratory pathogens simultaneously for differential diagnosis and meets the requirements of the World Health Organisation (WHO). Bosch Healthcare Solutions, together with Randox Laboratories Ltd., has developed one of the world’s first fully automated molecular diagnostic tests. The test is currently available on a laboratory-based system which tests up to 324 samples in 8 hours. Randox and Bosch Healthcare are working to make available a point of care test which can give results in less time.
The coronavirus SARS-CoV-2 is posing major challenges for healthcare systems and medical institutions worldwide. An ability to rapidly diagnose the virus is of invaluable help in curbing its exponential spread in many countries. Bosch’s new, fully automated rapid test for COVID-19 can help medical facilities such as doctors’ offices, hospitals, laboratories, and health centres make fast diagnoses. The rapid molecular diagnostic test runs on the Vivalytic analysis device from Bosch Healthcare Solutions. Developed in just six weeks, the rapid test can detect a SARS-CoV-2 coronavirus infection in patients in under two and a half hours – measured from the time the sample is taken to the time the result arrives. Another advantage of the rapid test is that it can be performed directly at the point of care. This eliminates the need to transport samples, which takes up valuable time. It also means patients quickly gain certainty about their state of health, while allowing infected individuals to be identified and isolated immediately. With the tests currently in use, patients must usually wait one to two days for a result.
“We want the Bosch rapid COVID-19 test to play a part in containing the coronavirus pandemic as quickly as possible. It will speed up the identification and isolation of infected patients,” says Dr. Volkmar Denner, chairman of the board of management of Robert Bosch GmbH; “Bosch’s rapid COVID-19 test will help contain the spread of the pandemic and break the chain of transmission more quickly.”
2. Project: Ventilators production + Geomiq
Summary: Bosch UK is working with Geomiq, an online platform that matches design engineers with manufacturers and has a heavy focus on medical devices, to replicate and 3D print the outer shell for vital ventilators. They just need to go-ahead from regulators.
Technology:
Test Kits
Headquarters:
United Kingdom
Founded Date:
N/A
Employees Number:
N/A
Funding Status:
N/A
Register and Claim Ownership